Accéder au contenu
Merck

The JMJD6/HURP axis promotes cell migration via NF-κB-dependent centrosome repositioning and Cdc42-mediated Golgi repositioning.

Journal of cellular physiology (2022-10-18)
Yun-Ru Jaoying Huang, Shao-Chih Chiu, Jeng-Sen Tseng, Jo-Mei Maureen Chen, Tong-You Wade Wei, Chen-Yu Chu, Hsu-Ting Eric Kao, Chieh-Yun Oprah Yang, Yong-Chun Erin Shih, Tsung-Ying Yang, Kun-Yuan Chiu, Chieh-Lin Jerry Teng, Chang-Tze Ricky Yu
RÉSUMÉ

Golgi apparatus (GA) and centrosome reposition toward cell leading end during directional cell migration in a coupling way, thereby determining cell polarity by transporting essential factors to the proximal plasma membrane. The study provides mechanistic insights into how GA repositioning (GR) is regulated, and how GR and centrosome repositioning (CR) are coupled. Our previous published works reveals that PRMT5 methylates HURP at R122 and the HURP m122 inhibits GR and cell migration by stabilizing GA-associated acetyl-tubulin and then rigidifying GA. The current study further shows that the demethylase JMJD6-guided demethylation of HURP at R122 promotes GR and cell migration. The HURP methylation mimicking mutant 122 F blocks JMJD6-induced GR and cell migration, suggesting JMJD6 relays GR stimulating signal to HURP. Mechanistic studies reveal that the HURP methylation deficiency mutant 122 K promotes GR through NF-κB-induced CR and subsequently CR-dependent Cdc42 upregulation, where Cdc42 couples CR to GR. Taken together, HURP methylation statuses provide a unique opportunity to understand how GR is regulated, and the GA intrinsic mechanism controlling Golgi rigidity and the GA extrinsic mechanism involving NF-κB-CR-Cdc42 cascade collectively dictate GR.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
PMA, for use in molecular biology applications, ≥99% (HPLC)
Roche
Anticorps anti-GFP, from mouse IgG1κ (clones 7.1 and 13.1)
Sigma-Aldrich
Bréfeldine A, ≥99% (HPLC and TLC), BioXtra, for molecular biology
Sigma-Aldrich
ML 141, ≥98% (HPLC)
Sigma-Aldrich
NF-kB Activation Inhibitor IV, The NF-kB Activation Inhibitor IV, also referenced under CAS 139141-12-1, controls the biological activity of NF-kB. This small molecule/inhibitor is primarily used for Inflammation/Immunology applications.